Humanized collagen antibodies and related methods
    13.
    发明授权
    Humanized collagen antibodies and related methods 失效
    人源化胶原抗体及相关方法

    公开(公告)号:US07566770B2

    公开(公告)日:2009-07-28

    申请号:US11486894

    申请日:2006-07-14

    IPC分类号: C07K16/00

    摘要: The invention provides an antibody, or functional fragment thereof, a grafted antibody, or functional fragment thereof, comprising one or more complementarity determining regions (CDRs) having at least one amino acid substitution in one or more CDRs of a heavy chain CDR, where the antibody or functional fragment thereof has specific binding activity for a cryptic collagen epitope. The invention also provides methods of using an antibody having specific binding activity for a cryptic collagen epitope, including methods of inhibiting angiogenesis, tumor growth, and metastasis.

    摘要翻译: 本发明提供抗体或其功能片段,其接枝抗体或其功能片段,其包含在重链CDR的一个或多个CDR中具有至少一个氨基酸取代的一个或多个互补决定区(CDR),其中 抗体或其功能片段对隐窝胶原表位具有特异性结合活性。 本发明还提供了使用具有对神经胶原表位具有特异性结合活性的抗体的方法,包括抑制血管发生,肿瘤生长和转移的方法。

    Aβ binding molecules
    16.
    发明授权
    Aβ binding molecules 有权
    A&bgr 结合分子

    公开(公告)号:US08105597B2

    公开(公告)日:2012-01-31

    申请号:US12504818

    申请日:2009-07-17

    IPC分类号: A61K39/395 C07K16/18

    摘要: The present invention encompasses isolated antibodies, or fragments thereof, that are humanized variants of murine antibody 266 which employ complementarily determining regions derived from murine antibody 266. The variant antibodies are useful for treatment or prevention of conditions and diseases associated with Aβ, including Alzheimer's disease. Down's syndrome, cerebral amyloid angiopathy, mild cognitive impairment, and the like.

    摘要翻译: 本发明包括分离的抗体或其片段,其是使用来自鼠抗体266的互补决定区的鼠抗体266的人源化变体。变体抗体可用于治疗或预防与A&bgr相关的病症和疾病,包括阿尔茨海默病 疾病。 唐氏综合征,脑淀粉样血管病,轻度认知障碍等。